Some good stuff in that release but did they just show 9...

Some good stuff in that release but did they just show 9 debt-laden Biotech companies that between them never produced one single dollar of profit and call them great? Some of those companies will be delisted or go broke, was that meant to be some sort of comparison? Throw in a cash burning Disc Medicine comparison that would be interesting as they are the best comparison stock to Clinuvel and they are much higher valued despite being an inferior company. Nice graph on how the company keeps growing profits and the share price keeps declining but not one single mention of daily shorting where the data is free and easy for everyone to see from the Australian government regulator ASIC.

50 thousand fake liquidity CUV short sells in the last one month alone.
About 100 thousand fake sells in the last 2 months.
300 thousand fake shares since 10th March 25 on the back of amazing half year financial results
1.5 Million fake Sell shares since Sept 2023 after exceptional financial full year results
About 3 Million fake sell shares total according to ASIC data
Extreme manipulation in a lightly traded company, usually closing shareprice near daily lows each day with a price 1 to 2% below VWAP

Easy to strike on shareholder behalf by deploying a 1.5 Million share buyback which is nearly untouched more than one year after much fanfare and strong verbal and written words from Clinuvel, never heard of a board treating its shareholders quite like this. Just fix this one thing and everything else can follow, it's not hard every other company with a share buyback manages to carry it out in a quite simple manner.

All IMO DYOR